Skip to main content
Evan Alley, MD, Oncology, Weston, FL

EvanWAlleyMD

Oncology Weston, FL

Hematologic Oncology, Thoracic Cancer

Physician

Dr. Alley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Alley's full profile

Already have an account?

  • Office

    2950 Cleveland Clinic Blvd
    Weston, FL 33331
    Phone+1 954-659-5840
    Fax+1 954-659-5810

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1999 - 2002
  • Sidney Kimmel Medical College at Thomas Jefferson University/TJUH
    Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1996 - 1999
  • University of Kansas School of Medicine
    University of Kansas School of MedicineClass of 1996

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2018 - 2025
  • PA State Medical License
    PA State Medical License 1997 - 2021
  • NJ State Medical License
    NJ State Medical License 2014 - 2019
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
  • CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Advanced Gene Therapy TR002 Moves to Phase III Clinical Trial for Mesothelioma
    Advanced Gene Therapy TR002 Moves to Phase III Clinical Trial for MesotheliomaSeptember 5th, 2019
  • Mesothelioma Shows Promising Response to Existing Immunotherapy Drug
    Mesothelioma Shows Promising Response to Existing Immunotherapy DrugMarch 31st, 2017
  • Pembrolizumab Shows Promise in Treatment of Mesothelioma
    Pembrolizumab Shows Promise in Treatment of MesotheliomaMarch 20th, 2017
  • Join now to see all

Professional Memberships